| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |